CD8A and neoplasm: In addition, CD8+ T cells demonstrated significantly higher proportions expressing the activation marker CD69+ in the tumor tissues (18.03 ± 4.17% of CD8+ T cells) compared to PB (3.14 ± 1.43% of CD8+ T cells).